An electrochemical sensor based on graphene oxide decorated with gold nanoparticles has been prepared for the simultaneous quantification of uric acid (UA) and ascorbic acid (AA) in urine samples. The gold interdigitated microelectrodes array (Au-IDA) has been modified using graphene oxide doped with gold nanoparticles (AuNPs-GO/Au-IDA), which was characterized by TEM, FE-SEM, XPS and cyclic voltammetry Excellent results were obtained for the separate quantification of UA and AA by chronoamperometry. The electrochemical sensor exhibits limits of detection (LODs) of 1.4 M and 0.62 M for AA and UA, respectively, limits of quantification (LOQs) of 4.6 M (AA) and 2.0 M (UA), and the working ranges obtained were between 4.6 M and 193 M for AA and between 2 M and 1.05 mM for UA. The repeatability was studied at 20 M providing coefficients of variation of 16 % for AA and 13 % for UA.
Introduction
Uric acid (UA; 7,9-dihydro-1H-purine-2,6,8(3H)-trione) is a weak acid present in extracellular fluids as sodium urate. Since anomalous UA levels in biological fluids have been linked to several diseases, researchers have developed several methods to detect it. Some illnesses like gout, hypertension, and cardiovascular disease, have been related to UA serum concentrations over 420 M [1] . Other conditions like neurodegenerative diseases may be caused by UA concentrations lower than 120 M [2] . Thus, UA normal levels in serum are established between 120 and 420 M, with slight variations depending on the gender. Since recent studies have provided evidences that altered levels of UA in serum might have a role in the development of disease states [3] , the manipulation of serum UA levels has been employed in the treatment of a variety of diseases [4] . Consequently, the development of a method to reliably quantify UA concentration in biological fluids has acquired increasing interest during the last decades.
As UA can be oxidised at common electrodes in aqueous solution, electrochemical sensors have been widely used for UA detection due to their advantages such as short analysis times, simple experimental procedures, and economical instrumentation.
However, the main disadvantage for the quantification of UA in biological fluids by electrochemical sensors is the presence of species whose oxidation takes place at potentials near the UA oxidation potential on most of the common electrodes. This occurs with the oxidation of ascorbic acid (AA), resulting in a poor selectivity towards UA [5] .
Moreover, the determination of AA in biological fluids is also very interesting, since it is well-known that AA is related to some diseases, and that it cannot be synthetized by humans and it should be incorporated via diet [6] . A normal range of AA concentrations in plasma has been set between 50 and 80 M [7, 8] . An insufficient amount of AA causes symptoms of scurvy [9] , but high concentrations results in gastric irritations [10] .
Furthermore, AA has an important role in healthy cell development, normal tissue growth, and the healing of injuries, among other biochemical functions [11] . As a result, a huge effort has been done in order to detect and quantify both analytes separately and simultaneously in biological fluids, such as plasma or urine.
Electrochemical sensors based on carbon materials are commonly used for their low cost, good chemical stability, good electron transfer kinetics, and biocompatibility.
Specifically, graphene and its derivatives have been widely used in electrochemical sensors due to their physical and electrochemical properties [12] . At present, the use of graphene oxide (GO), the oxygenated derivative of graphene, is the most promising material for the preparation of colloidal suspensions due to oxygen-containing functional groups on its surface, which provide hydrophilicity [13] , facilitating its dispersion in aqueous media, and conferring high tolerance towards chemical modification [14] . As a result of the easy processing and handling of GO and its electrochemical flexibility, most of the recent efforts in the electrochemical carbonbased sensors have been based on this material. The advantages of GO allow the preparation of more concentrated dispersions, resulting in a shorter time for electrode modification. Moreover, the oxygen functional groups are amenable for bioconjugation toward the construction of biosensors, immunosensors and other devices [12] . The oxygen functional groups on GO can be reduced and regenerated electrochemically [15] with better electrical properties, high density of defects, and edge-like planes. Such combined properties enhance fast electron transfer, enabling its application in electrochemical sensing and biosensing. In order to increase its sensitivity and selectivity, GO usually is functionalised with other materials, such as nanoparticles or polymers [16] [17] [18] [19] [20] [21] . At present, several of the recent studies have combined gold nanoparticles with graphene-based materials for electrochemical sensors and biosensors, trying to take advantage of the catalytic character and biocompatibility of gold. The presence of surface oxygen groups in GO increases the interaction between the metal catalyst and support [13] .
The detection and quantification of UA and AA have been performed by differential pulse voltammetry (DPV) with an electrochemical sensor based on graphene oxide modified with gold nanoparticles, achieving limit of detection (LOD) of 20 M and 200 M, respectively [22] . However, the LOD obtained for AA should be improved due to the fact that levels of AA in plasma for healthy people are usually lower [7, 8] and the detection of concentrations lower than 20 M is also interesting [8, 23] . The simultaneous determination of AA and UA within other compounds has been evaluated using a sensor based on overoxidized polyimidazole and graphene oxide copolymer by cyclic voltammetry [24] . The proposed sensor exhibited a linear response range for AA between 75 µM and 2275 µM, and for UA between 3.6 µM and 249.6 µM. Several works have been reported for the electroanalytical determination of UA and AA in the presence of other compounds and most of them used a glassy carbon electrode as support of the modified-GO [17, 18, 20] . Benvidi et al. fabricated a reduced graphene oxide (RGO), gold nanoparticles and 2-(3,4-dihydroxyphenyl)benzothiazole-modified glassy carbon electrode for the simultaneous determination of levodopa, uric acid and folic acid [17] . Only a few publications may be found related with modified interdigitated arrays [21, 25] or screen-printed electrodes [19] , with a small size which makes the development of portable Lab-on-a-Chip devices feasible.
The aim of the present work is the preparation by a one-step method of an electroactive material based on graphene oxide with gold nanoparticles with low loadings supported on gold interdigitated microelectrodes. Gold nanoparticles were synthesized following a method which allow not only fine nanoparticle size and distribution control but also avoid the use of additional reducing agents, improving the cost-efficiency of the synthetic process [26] . The modified electrodes have been assessed in the simultaneous detection and quantification of AA and UA in biological fluids, also improving the limits of detection hitherto achieved by using graphene oxide as support of metallic nanoparticles. To the best of our knowledge, this is the first time that an interdigitated electrode array is modified with Au-decorated graphene oxide sample, allowing the development of portable sensors for the simultaneous UA and AA determination.
Experimental

Reagents and equipment
Uric acid (≥99%, crystalline) and L-Ascorbic acid (reagent grade, crystalline), dopamine hydrochloride, glucose and epinephrine standard chemicals, glutaraldehyde (50%) and poly(styrenesulfonate) (PSS) were provided by Sigma-Aldrich. Potassium dihydrogen phosphate (KH2PO4) and Potassium phosphate dibasic (K2HPO4) obtained from Emsure® and Sigma-Aldrich respectively, were used to prepare buffer solution (PBS, 0.25 M, pH 7.0). Sulphuric acid (98%) was provided by AnalaRNormapur®.
Ultrapure water was obtained by a treatment in Purelab Ultra Elga with a resistivity of 18 MΩ·cm. Sodium hydroxide proanalysis (NaOH) was purchased from Merck.
The reagents employed in the gold nanoparticles synthesis, (poly-n-vinylpyrrolidone (PVP), anhydrous ethylene glycol, sodium tetrachloroaurate dehydrate (NaAuCl4·2H2O), methanol and sodium hydroxide (NaOH; 99.99% purity) were purchased from Sigma-Aldrich. Isopore Membrane Filters (0.2 m GTTP) from Millipore were employed for cleaning and drying of the material synthesized and absolute ethanol was purchased from PROLABO. 
Preparation of graphene oxide decorated with gold nanoparticles
Synthesis and purification of graphene oxide decorated with gold nanoparticles
Graphene oxide was prepared following the Hummers method improved by Marcano et al. [27] .
Gold nanoparticles were synthesized following a method based in the methodology described by Dominguez et al. [26] with several modifications which allow not only fine nanoparticle size and distribution control (as most chemical methods for the synthesis of metallic colloids, which represents a significant advantage over other methods) but also avoid the use of additional reducing agents, improving the cost-efficiency of the synthetic process. In order to control the nanoparticle size and to obtain a good size distribution, the synthesis was performed in an inert atmosphere in a Schlenk system unless stated otherwise.
In order to decorate the graphene oxide support with a 10% (w/w) of gold nanoparticles, the following method was applied. For solution 1, in a two-necked, round-bottom flask, 0.075 g of graphene oxide and 0.120 g of poly-n-vynilpyrrolidone were added to 12 mL of anhydrous ethylene glycol. The mixture was maintained at 80ºC under stirring conditions for 1 h. For solution 2, in a two-necked, round-bottom flask, 0.022 g of gold precursor (NaAuCl4·2H2O) were dissolved in 5 mL of methanol under stirring at room temperature during 1 h. The resulting solution was of yellow color.
After that, solution 1 was cooled at 0ºC with an ice bath and solution 2 was added to solution 1, keeping the stirring to ensure a good homogenization. The pH of the resulting solution was adjusted to 9-10 by adding 0.5 mL of a NaOH 1 M solution and the resulting solution was heated at 100 ºC under vigorous stirring for 2 h. After 2 hours the flask was removed from the bath and cooled to room temperature.
The GO decorated with AuNPs was purified with a vacuum filtration system. The sample on the filter was cleaned with an excess of ethanol and the solid obtained was dried in a vacuum oven at 40ºC for 24 h.
Graphene oxide decorated with gold nanoparticles dispersion
Dispersions of 1 mg·mL -1 of graphene oxide (GO) and graphene oxide modified with gold nanoparticles (AuNPs-GO) were prepared in water. Both dispersions contained 1%
PSS in order to achieve the dispersion of the carbon material. To obtain a proper dispersion, an ultrasound probe was applied for 10 min (QSonica, MODEL Q125, 100W). In order to avoid localized heating during sonication, the vessels containing the sample suspensions were immersed in an ice bath.
Preparation of Au-IDA modified electrodes
First, cyclic voltammetry was performed in order to clean the gold (thin film of 150 nm) interdigitated microelectrodes array (Au-IDA1, Micrux). The size of the working electrode is 10 µm. Then, ten cycles between -1.5 V and 1.5 V versus the gold pseudoreference at 0.1 V s -1 in 0.05 M H2SO4 were applied.
Then the Au-IDA microelectrode was modified by casting the aqueous AuNPs-GO dispersion obtaining the AuNPs-GO/Au-IDA modified electrode. An Au-IDA modified electrode with GO was also prepared for electrochemical characterization. In both kinds of electrodes, the weight of the graphene oxide-based material deposited was 5 g. The method for the deposition was the dropwise addition of 0.5 µL of each dispersion and drying under an infrared lamp. Finally, 0.75 L of glutaraldehyde were added to ensure that the solid material remains on the surface of the Au-IDA electrode. The scheme shown in Figure 1 illustrates the preparation procedure for the sensor electrode.
Electrochemical methods
All electrochemical measurements were carried out on a BIOLOGIC SP-300 potentiostat. A three-electrode configuration was used, in which the electrode modified with graphene oxide-based material was the working electrode (WE), a reversible hydrogen electrode (RHE) was the reference electrode (RE) and a platinum wire was the counter electrode (CE). The electrochemical cell was completely deoxygenated during measurements by bubbling nitrogen. All potentials presented are referred to the RHE electrode.
To identify the analytes, cyclic voltammetry was carried out in order to know at which potential the oxidation of UA and AA occurs. It is important to highlight that since the pH of the physiological fluids employed is higher than the pKa1 of these analytes, the quantification of ascorbate monoanion (HA -) [8] and urate (HU -) [28] has been determined. However, these analytes will be referred to as AA and UA throughout the manuscript, respectively.
For real samples determination, filtered urine was diluted 20 times in PBS (0.25 M, pH 7.0) and no other treatment was carried out. Figure 2 ), the oxidation process of the gold surface at 1.5 V is observed during the positive scan and the reduction peak at 1.1 V related to the desorption of oxygen from the gold surface can be clearly seen. In addition, a high cathodic current can be seen due to the electrocatalytic effect of the AuNPs in the hydrogen reduction reaction on the gold surface. Figure 3 shows two representative TEM images for the GO and the AuNPs-GO dispersions. As it can be seen in Figure 3A , single layer structured GO flakes with a smooth surface were provided. The TEM micrograph of AuNPs-GO dispersion ( Figure   3B ) shows a uniform distribution of the AuNPs on GO surface, with an average particle size between 4-9 nm, as shown in the histogram ( Figure 3C ). The presence of wrinkles in Figure 3A is an evidence of the conformational flexibility of GO, which is the reason why GO is locally folded in double or multiple layers [29] .
Results and
Structural characterization
The surface morphology of the modified electrode (AuNPs-GO/Au-IDA) was characterized by FE-SEM. Figure 4 presents a material with several layers of graphene.
The spots observed in Figure 4 correspond to the AuNPs. It can be observed that the nanoparticles are homogeneously distributed on the electrode, and the entire Au-IDA electrode surface is covered. Figure 4 also shows the same sheet wrinkling, which indicates the presence of several layers of GO.
XPS was used in order to determine the state of the main constituents of the dispersion (namely, Au, C, and O). The elemental contents of carbon, oxygen and gold were also quantified for both dispersions. Figure 5 shows the XPS spectra of gold for the AuNPs- can be seen, which may be ascribed to the presence of the metallic particles. This observation is corroborated by the fact that the C1s XPS spectra for both samples (results not shown) were very similar, with negligible variations in the relative intensities of the peaks which may be ascribed to graphitic carbon (peak at 284.9 eV), phenol or ether-related groups (286.3 eV), quinone-related groups (287.5 eV), and carboxyl or ester-related groups (288.9 eV) [30] .
Electrochemical determination of AA and UA on AuNPs-GO/Au-IDA electrodes.
The electrochemical oxidation activity of AuNPs-GO/Au-IDA modified electrode towards UA and AA was investigated. Figure 6 shows the voltammograms obtained for Figure 8A . As it can be observed in Figure 8A (inset), the analytical range studied seems to be characterized by two linear ranges, which means that the functional relationship is not linear at all.
The reduction of the concentration range is one of the most widespread strategies to solve this [31] . To achieve this, a working response range between 4.6 M and 193 M All analytical figures of merit calculated for the quantification of AA and UA are summarized in Table 1 . The LOD was determined empirically, measuring progressively more diluted concentrations of the analyte. The LOD was the lowest concentration whose signal could be clearly distinguished from the blank. Moreover, the LOQ was calculated as 3.3 times the LOD (LOQ = 3.3LOD) [32] . The coefficient of variation values (CV) were obtained for 3 replicates at 20 M concentration level of UA and AA.
Simultaneous detection of AA and UA
In order to study the simultaneous detection of AA and UA, cyclic voltammetry was performed in a solution containing the two analytes. Figure 9 shows the voltammograms obtained for the AA and UA interference study. Figure 9A The results obtained for the addition of UA aliquots in a solution containing 275 M AA are presented in Figure 9B . As it is exhibited in the voltammetric curves, the current of the voltammetric peak owing to AA oxidation (E = 0.75 V) decreased after UA aliquots were added. Then, it seems that UA interferes in the voltammetric response of AA. Then, the amperometric responses for minimum and maximum levels of AA and UA were determined to have a broad knowledge about how each analyte interferes in the determination of the other.
The interference study of UA and AA has been performed by chronoamperometry at 0.75 V and 1.0 V, respectively and with concentrations higher than the normal values in serum. Figure 10 and Figure 11 display the i-t curves recorded for the interference study. Figure 10 On the other hand, Figure 11 shows the effect of the addition of AA with a concentration between 30 M and 90 M in the UA oxidation current at 1.0 V when the UA concentration is 120 M (Figure 11A ) or 450 M ( Figure 11B ) in the solution. It can be observed for the lowest UA concentration established in serum (120 M, Figure   11A ) that additions of AA lead to an increase on the current measured at 1.0 V potential. That means that AA interferes in the quantification of low concentrations of UA.
However, when the UA concentration is the highest allowed for healthy people (around 450 M), Figure 11B depicts how the AA additions lead to a small increase in the measured current (21, 11 and 33 nA for the 1 st , 2 nd and 3 rd aliquot, respectively). Taking into account that confidence limits for this concentration values are about  30 nA, this increase can be considered included in the experimental error of the measurements. As a result, this method is able to quantify UA in unhealthy people (UA concentration at least 450 M) in presence of AA up to a concentration of 60 M.
In order to apply the present method to healthy people, whose UA levels are lower than 450 M, the following strategy may be applied: 1) calibration curve of AA at 0.75 V, 2) calibration curve of UA in the presence of the amount of AA in the real sample at 1.0 V potential. Preparation of calibration curve 2 requires knowing the concentration of AA in the sample beforehand. In order to avoid the preparation of a calibration curve (i-t curve at 1.0 V) after knowing the amount of AA present in the real sample, it becomes advisable to prepare several i-t curves with different AA concentrations between 10 M and150 M. Thus, the method can be applied in people with AA levels lower or higher than the fixed range levels. The sample, which contains a mixture of AA and UA will be subjected to chronoamperometry. First of all, the i-t curves at 0.75 V and 1.0 V potential of the sample will be recorded. The i-t curve at 0.75 V will provide a current intensity value (iAA,1), which is directly related to the concentration of AA (CAA) by the linear function of calibrate curve 1. From the i-t curve at 1.0 V, a second current value (iT = iAA,2 + iUA) will be obtained, from which the amount of UA in the sample can be quantified by using the linear function of calibrate curve 2, which has been made with the amount of AA that was present in the real sample.
Study of other interferences
Other possible interferences, like glucose, dopamine (DP) and epinephrine (EP) were investigated by chronoamperometry at 0.75 V and 1.0 V in PBS (0.25 M, pH 7.0), to know if the presence of these analytes in physiological fluids are able to modify the signal belonging to the oxidation of AA and UA.
In order to study the interference of these compounds, concentrations of glucose (5 mM) [33] , dopamine (1 M) [34] , [35] and epinhefrine (0.5 M) were used, being these concentrations higher than the usually found in serum [36] , [37] . Interferences at 0.75 V and 1.0 V were investigated in a 50 M AA solution and 420 M UA solution, respectively, being these concentrations usually found in serum, and the results obtained are displayed in Figure 12 .
As it can be observed in Figure 12 the addition of glucose, dopamine and epinephrine does not change the current intensity corresponding to the oxidation of AA at 0.75 V ( Figure 12A ) and UA at 1.0 V ( Figure 12B ). As a result of that, it can be concluded that the method developed is able to quantify AA and UA, even in the presence of the analytes studied above.
Finally, Table 2 shows a comparison of some analytical parameters obtained in this work, with others results previously reported. It can be observed that the proposed sensor is competitive, representing therefore a good and interesting alternative.
Moreover, the LODs and LOQs achieved with the proposed sensor are greatly improved with respect to those shown in a recent publication about this topic [22] , whose similarity lies in the same electrode material.
Human urine samples
A human urine sample from a healthy person was analyzed by the standard addition method due to matrix effects, which caused the displacement of the oxidation peaks Inter-sensor reproducibility was studied using five electrodes prepared using the method described in section 2.3. The obtained results yielded coefficients of variation (CV) values about 27% for AA and about 9% for UA determination which prove the reliability of the developed method ( Figure 13 ).
Conclusions
An 
